Weekly Roundup: Glanbia launches share buy-back program, Sabinsa scores Mexican patent

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

This week in nutrition news, Evolva has secured up to US$13 million in financing from Nice & Green, while the debate over the use of N-acetyl-L-cysteine (NAC) in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Deerland Probiots & Enzymes is eying a host of opportunities for its probiotic species Bacillus subtilis, whose patent application has just been published.It... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Glanbia Nutritionals partnered with Ixoreal Biomed to optimize KSM-66 Ashwagandha root extract with NutraShield technology to provide... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Global ingredient and service solution provider Glanbia Nutritionals is investing €1.4 million (US$1.6 million) to upgrade its R&D facility in Kilkenny,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The US nutrition industry hit back at the Food and Drug Administration (FDA) over the legal issues surrounding the use of antioxidant N-acetyl-L-cysteine (NAC) in... Read More

trans